About

Apexray Biotech is an pharmaceutical BD and licensing advisory focused on international markets.

The focus spans APIs, finished dosage forms, CDMO/CMO partnerships, licensing-out opportunities for generics, 505(b)(2) products & clinical-stage assets across Europe, North America, Japan and Asia-Pacific (APAC) – from identifying the right partners to structuring and negotiating cross-border supply, manufacturing and licensing agreements.

Areas of Expertise

Experience across key areas of pharmaceutical business development

API Sourcing Strategy

Experience in API sourcing and supplier evaluation across Taiwan, India, China, Europe and other key hubs.

Work has included qualifying manufacturers, comparing technical and regulatory fit, and benchmarking supply terms to support reliable API supply for products targeting regulated markets.

Cross-Border CDMO & Manufacturing Partnerships

Project work has covered assessing CDMO/CMO capabilities, aligning process and regulatory requirements for specific dosage forms, and mapping suitable partners in Europe, the US, Japan and other highly regulated markets.

Experience also includes supporting the preparation and evaluation stages for tech transfer, scale-up and long-term manufacturing collaborations.

Experience spans opportunity assessment, partner targeting and BD preparation for licensing-out discussions across generics, 505(b)(2) products and clinical-stage assets.

Work has involved analysing value and deal options, structuring proposals and supporting data-driven negotiations for co-development and licensing agreements in international markets.

Licensing & Co-Development Deals 【Generic, 505(b)(2), clinical-stage new drug】